HNO Journal Impact Factor & Information

Publisher: Springer Verlag

Journal description

Die Zeitschrift HNO berichtet über aktuelle wissenschaftliche Ergebnisse aus Klinik und Forschung. Die Herausgeber sind bemüht bei der Auswahl der Beiträge auch die Interessen des in der Praxis tätigen HNO-Arztes zu berücksichtigen. Zugleich wird in diagnostischen und therapeutischen Fragen des Fachgebietes eine kontinuierliche Fortbildung vermittelt. Über wichtige Kongresse und Symposien wird zusammenfassend in kurzen Berichten informiert. Zur Publikation eingereichte Manuskripte müssen bei Untersuchungen an Probanden oder Patienten die Erklärung enthalten daß das Versuchsprotokoll von einer Ethikkomission begutachtet wurde und somit den ethischen Standards der Deklaration von Helsinki 1964 in der jeweils gültigen Fassung (Pharm. Ind. Nr. 12/1990 sowie Bundesanzeiger Nr. 243a vom 29.12.1989) entspricht. Gleichzeitig ist die Einwilligung der Versuchsperson nach Aufklärung im Text des Manuskriptes zu fixieren. Hinweise die auf die Identität der Versuchsperson schließen lassen sind zu vermeiden. Tierversuchsprogramme müssen den Passus enthalten daß die "Principles of laboratory animal care" (NIH publication No. 86-23 revised 1985) eingehalten wurden soweit nicht zusätzlich besondere nationale Regelungen zu beachten sind (für die Bundesrepublik Deutschland ist dies das Tierschutzgesetz in aktueller Fassung). Die Herausgeber behalten sich deshalb das Recht vor Manuskripte abzulehnen die den o.g. Anforderungen nicht entsprechen. Der Autor haftet bei Verstoß gegen die o.g. Anforderungen oder bei falschen Angaben.

Current impact factor: 0.54

Impact Factor Rankings

2015 Impact Factor Available summer 2015
2013 / 2014 Impact Factor 0.538
2012 Impact Factor 0.42
2011 Impact Factor 0.4
2010 Impact Factor 0.543
2009 Impact Factor 0.464
2008 Impact Factor 0.57
2007 Impact Factor 0.653
2006 Impact Factor 0.533
2005 Impact Factor 0.484
2004 Impact Factor 0.514
2003 Impact Factor 0.473
2002 Impact Factor 0.507
2001 Impact Factor 0.62
2000 Impact Factor 0.722
1999 Impact Factor 0.486
1998 Impact Factor 0.675
1997 Impact Factor 0.621

Impact factor over time

Impact factor
Year

Additional details

5-year impact 0.45
Cited half-life 8.10
Immediacy index 0.13
Eigenfactor 0.00
Article influence 0.09
Website HNO website
Other titles HNO (Online), Hals- Nasen- Ohrenheilkunde
ISSN 1433-0458
OCLC 42964434
Material type Document, Periodical, Internet resource
Document type Internet Resource, Computer File, Journal / Magazine / Newspaper

Publisher details

Springer Verlag

  • Pre-print
    • Author can archive a pre-print version
  • Post-print
    • Author can archive a post-print version
  • Conditions
    • Author's pre-print on pre-print servers such as arXiv.org
    • Author's post-print on author's personal website immediately
    • Author's post-print on any open access repository after 12 months after publication
    • Publisher's version/PDF cannot be used
    • Published source must be acknowledged
    • Must link to publisher version
    • Set phrase to accompany link to published version (see policy)
    • Articles in some journals can be made Open Access on payment of additional charge
  • Classification
    ​ green

Publications in this journal

  • HNO 08/2015; DOI:10.1007/s00106-015-0051-4
  • [Show abstract] [Hide abstract]
    ABSTRACT: At the Annual Meeting of the American Society of Clinical Oncology (ASCO) 2015, results of current trials dealing with nonsurgical primary treatment of locally advanced head and neck cancer were presented. Regarding concomitant chemoradiotherapy (CRT), studies focused on the dosage and sequence of cisplatin administration are currently particularly featured. Amongst these, a study on dosage reduction in human papilloma virus (HPV)-positive patients was presented. Other investigations addressed substances as alternatives for cisplatin, particularly carboplatin and targeted therapeutic agents. The comparison of concomitant and sequential CRT (induction chemotherapy (ICT) prior to CRT) is still one of the main topics. In addition, studies modifying the ICT regimen or combining subsequent radiotherapy (RT) with the epidermal growth factor receptor (EGFR) antibody cetuximab were presented. A selection of the most important trials are summarized in this article.
    HNO 08/2015; DOI:10.1007/s00106-015-0053-2
  • HNO 08/2015; DOI:10.1007/s00106-015-0049-y
  • [Show abstract] [Hide abstract]
    ABSTRACT: The past century saw rapid development of craniofacial prostheses. Particularly the challenging issue of surgical fixation was the subject of intensive research and development. During the past three decades, the principle of osseointegration has proven to provide a reliable method for epithesis fixation. The continuous technical development of implant systems has led to almost minimally invasive surgical techniques, with ever increasing stability of the implants. Osseointegrated implants are a proven and durable solution in the rehabilitation of the patient with a defect in the craniofacial region. Overall complication rates are low. The design and mechanics of the implants, as well as the artificial body of the epithesis itself, are topics of current medical-technical research by anaplastologists and surgeons. Finally, functional prostheses, such as the tracheostomy epithesis, deserve particular attention.
    HNO 08/2015; DOI:10.1007/s00106-015-0035-4
  • [Show abstract] [Hide abstract]
    ABSTRACT: Cerebral venous and dural sinuses thrombosis (CVT) is a relatively rare but very serious disease, because of the risk of mortality. Cardinal symptoms are usually severe sudden-onset localized headaches, which may or not be accompanied by focal or generalized neurological deficits or seizures. It is particularly important to consider CVT in the presence of underlying prothrombotic conditions (genetically predisposed or acquired defects of the coagulation system) or well-known risk factors (hormonal contraception, pregnancy, puerperium, smoker status). Based on clinical findings, diagnosis is established using neuroimaging (MRI and MR venography, CT and CT venography) and D-dimer measurement. In the case of early diagnosis and onset of antithrombotic treatment, the prognosis is good. Otherwise there is a high risk of irreversible neurological deficits or even mortality. In daily clinical routine, where many patients present with similar or unspecific symptoms-most of which are harmless-it is thus particularly important that CVT be considered in the differential diagnosis.
    HNO 08/2015; DOI:10.1007/s00106-015-0044-3
  • HNO 08/2015; DOI:10.1007/s00106-015-0040-7
  • [Show abstract] [Hide abstract]
    ABSTRACT: Spiradenocarcinomas are rare malignant tumors that originate from the sweat glands of the skin and demonstrate aggressive growth. We report the case of an 86-year-old female patient presenting with a growth on the forehead which had been apparent for 2 years. After surgical removal of the tumor, histological workup culminated in the diagnosis of a spiradenocarcinoma. Surgical margins were free of tumor on pathological examination. Metastasis was excluded by positron-emission tomography-computed tomography (PET-CT). Due to the advanced age of the patient and the absence of metastatic disease, no adjuvant therapy was performed. Six months postoperatively there is no evidence of relapse.
    HNO 08/2015; DOI:10.1007/s00106-015-0045-2
  • [Show abstract] [Hide abstract]
    ABSTRACT: Resection margins of melanomas in the head and neck region often have to be adapted according anatomical circumstances. In the case of thicker primary tumors or after complete resection of locoregional lymph node metastases, adjuvant therapy with interferon-α can be performed; in some cases, adjuvant radiotherapy may also be indicated. In the case of inoperable lymph node or distant metastases, systemic treatment is required. Beside well-established mono- or polychemotherapy regimens, newer targeted therapies with BRAF inhibitors (vemurafenib, dabrafenib), mitogenic-activated protein kinase (MEK) inhibitors (trametinib, binimetinib, and cobimetinib), and kinase inhibitors (imatinib, sunitinib, nilotinib, dasatinib) are also available.
    HNO 07/2015; DOI:10.1007/s00106-015-0034-5
  • [Show abstract] [Hide abstract]
    ABSTRACT: The obliteration of mastoid cavities is an appropriate intervention to sustainably improve patients' quality of life. After 30 years, 843 cases of mastoid obliteration were analyzed from the pool of data resulting from 16,000 surgical procedures on the ear. The materials used by the authors included cartilage/bone, Palva flaps, and bone pâté; as well as alloplastic material such as hydroxyapatite (HA) and bioactive glass granules (BAG S53P4) from BonAlive® (BonAlive Biomaterials Ltd., Turku, Finland). Pathological findings included rejection with inflammation, granulation of the auditory canal reconstruction, unclear retraction pockets, as well as shrinkage and cicatricial contraction. The follow-up interval was at least 4 months, with an average of 33 months (standard deviation ± 27.8 months). Use of HA was discontinued after 18 cases, because rejection and retraction occurred in 33 % of patients. The same applied for bone pâté after 33 cases, with a pathological finding in 21 %. The Palva flaps (145 cases) showed pathological findings in 21 % of cases, primarily in the form of shrinkage (7 %) and retractions (10 %). Cartilage/bone pieces (516 cases) and BAG S53P4 (133 cases) only showed abnormal postoperative findings in 8 % and 3 %, respectively. It is recommended to focus particularly on auditory canal and canal entrance expansion during mastoid obliteration surgery. When using the bioactive glass granules, postoperative use of a mini-drain for 1-2 days is beneficial, in order to avoid accumulation of seroma fluid in the mastoid. In our experience, a combination of BAG S53P4 and cartilage as cover is a suitable material for cavity obliteration.
    HNO 07/2015; DOI:10.1007/s00106-015-0028-3
  • [Show abstract] [Hide abstract]
    ABSTRACT: Inpatient treatment of chronic complex tinnitus can be necessary for patients with a high symptomatic strain, mostly accompanied by a corresponding mental comorbidity, and/or for patients that can only perceive their psychogenic suffering through somatization into tinnitus. We report the results of 368 consecutively treated inpatients with chronic complex tinnitus. Patients' audiometric data were collected, and at the beginning and end of treatment, the Mini-Tinnitus Questionnaire (Mini-TQ12; Hiller und Goebel) was completed, as was the German version of the Hospitality Anxiety and Depression Score (HADS). Effect sizes were calculated for both questionnaires. Mean treatment duration was 38.8 days (standard deviation, SD: 13.6 days). The main therapeutic elements were intensive disorder-specific neurotologic counselling and psychoeducation; improvement of hearing by fitting of hearing aids, complemented by an individualized hearing therapy; and intensive individual and group-based psychotherapy. In addition to tinnitus, 82.1 % of the patients had reduced hearing requiring rehabilitation with hearing aids. After hospitalization, a highly significant improvement in tinnitus strain could be demonstrated by the Mini-TQ12. Furthermore, a significant reduction in the depression and anxiety components of HADS was also achieved, with high effect sizes of 1.6 to 2.2. No reduction of tinnitus symptoms to a medium- or low-range level was experienced by 8.9 % of patients. With corresponding symptomatic suffering, disorder-specific inpatient tinnitus treatment comprising neurotologic and psychosomatic alignment can achieve medium- to high-range therapeutic effects.
    HNO 07/2015; DOI:10.1007/s00106-015-0046-1
  • HNO 07/2015; DOI:10.1007/s00106-015-0023-8
  • HNO 07/2015; DOI:10.1007/s00106-015-0021-x
  • HNO 07/2015; DOI:10.1007/s00106-015-0039-0
  • [Show abstract] [Hide abstract]
    ABSTRACT: A patient presents with a keratocystic odontogenic tumour of the left maxillary sinus. In computed tomography scans, extensive pressure-induced osseous atrophy of the sinus walls is detected. Endoscopic cystectomy of the tumour was performed, with subsequent clinical follow-up. A second computed tomography scan revealed almost complete regeneration of the sinus walls. Where spontaneous regeneration of osseous structures is possible, restraint should be exercised when assessing indications for bony reconstruction during initial conservative surgery such as enucleation.
    HNO 07/2015; DOI:10.1007/s00106-015-0038-1
  • [Show abstract] [Hide abstract]
    ABSTRACT: The influence of bilateral cochlear implants (CI) and unilateral CI on the self-reported listening effort in standardized situations is being assessed. The sample consisted of 34 bilateral and 38 unilateral adult CI users. Unilateral CI users had at least severe hearing loss in the non-implanted ear and had been fitted with a hearing aid. The listening effort has been defined as a subjectively perceived effort in understanding a speaker. Patients were administered a customized questionnaire containing nine examples of listening situations with different demands. The listening effort expended in each situation had to be rated on a six-step scale. Answers were analyzed using repeated measures ANOVA, including the factors "level of background noise," "listening duration," and the covariates "patient age" and "time since CI implantation." Only the factors "level of background noise" and "listening duration" were significant (p = 0.024 and p = 0.001 respectively). Unilateral versus bilateral CI was not significant (p = 0.17). Nevertheless, bilateral CI users reported a lower degree of listening effort than unilateral users in all of the nine situations asked about in the questionnaire (binomial test: p = 0.002). We conclude that bilateral CI use has some effect on reducing listening effort, but compared with unilateral use the effect is possibly not very great.
    HNO 07/2015; DOI:10.1007/s00106-015-0020-y
  • [Show abstract] [Hide abstract]
    ABSTRACT: About 15 % of all cutaneous melanomas develop in the head and neck region. Mucosal melanomas are rare and represent only 1 % of all melanomas, however, most frequently, these are located in the nose, the paranasal sinuses and the oral cavity. Visual diagnosis and reflected-light microscopy are relevant for the evaluation of melanoma-suspect lesions. Histological investigation of resected tumors need special skills of the histopathologist and includes in case of high-risk tumors investigations of mutations in the tumor tissue concerning NRAS, BRAF and KIT. The risk of lymphatic or hematogeneous spread rises with increasing tumor thickness and the presence of further prognostic risk factors such as ulceration of the primary tumor or the presence of mitoses within the tumor.
    HNO 07/2015; DOI:10.1007/s00106-015-0024-7
  • [Show abstract] [Hide abstract]
    ABSTRACT: Head and neck tumors are rare entities in neonates. Hamartomas are benign congenital neoplasms. To date, there is a lack of sufficient epidemiological data concerning hamartomas in the field of otorhinolaryngology. We retrospectively analyzed experiences at the Charité over the past 10 years in an ICD-10-based manner. Our otorhinolaryngology department maintains close cooperation with the level 1 perinatal center on our campus. The authors identified 3 patients suffering from fibrous hamartomas. This corresponds to an incidence of 2-3/30,000 newborns. The clinical aspects and courses are described in detail. Experiences with the management of hamartomas obstructing the upper aerodigestive tract are described. Head and neck hamartomas are very rare malformations. They possess the ability to cause otorhinolaryngological emergencies in newborns. Interdisciplinary management and histological assessment are mandatory. Anmerkung.
    HNO 07/2015; DOI:10.1007/s00106-015-0027-4
  • [Show abstract] [Hide abstract]
    ABSTRACT: In dental surgery today a variety of bone substitutes are used for sinus lift. After the increased application of synthetics during the last decade there has now been a move back to autologous bone transplants, combined with allogenic and xenogenic augmentation materials. The effects of transforming growth factors and recombinant equivalents of bone morphogenetic proteins remain to be seen. Covering the augmented area with a collagen membrane is the basic standard in many cases. Concomitant illnesses of dental origin or of the maxillary sinus have to be assessed prior to any sinus lift. Once complications such as laceration of the Schneiderian membrane, infection or adverse reaction have occurred, early and consistent therapy is required.
    HNO 07/2015; DOI:10.1007/s00106-015-0031-8
  • HNO 07/2015; DOI:10.1007/s00106-015-0036-3